Mirador Capital Partners »

Aktis Oncology shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Aktis Oncology (AKTS) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.3M 40k 32.23

More positions owned by Mirador Capital Partners

Invesco Exch Trd Slf Idx Invsco Blsh 26 (BSJQ)
Invesco Exch Trd Slf Idx Buletshs 2027 (BSJR)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Kla Corp Com New (KLAC)
Abbvie (ABBV)
Cytokinetics Com New (CYTK)
Palo Alto Networks (PANW)
Chevron Corporation (CVX)
NVIDIA Corporation (NVDA)
Intel Corporation (INTC)

View all positions for Mirador Capital Partners

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology